Lin Xichen's Form 4 filing
Structure Therapeutics Inc. (GPCR) · filed Jun 5, 2024
- Accession no.
- 0001415889-24-015683
- Filed
- Jun 5, 2024, 7:38 PM ET
- Trade date
- Jun 3, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 4 derivative transactions. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lin XichenCIK 0001962926 | Officer (CHIEF SCIENTIFIC OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 3, 2024 | Ordinary Shares | MOption exerciseAcquired | +106,200 | $0.34 | +$36,108 | 191,907 | Direct | |
| Jun 3, 2024 | Ordinary Shares | CConversionDisposed | −106,200 | $0.00 | $0 | 85,707 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 3, 2024 | Ordinary Shares | MOption exerciseDisposed | −106,200 | $0.00 | $0 | 213,800 | Direct | |
| Jun 3, 2024 | Ordinary Shares | CConversionAcquired | +106,200 | $0.00 | $0 | 35,400 | Direct | |
| Jun 3, 2024 | Ordinary Shares | SSaleDisposed | −53,100 | $45.00 | −$796,500 | 17,700 | Direct | |
| Jun 3, 2024 | Ordinary Shares | SSaleDisposed | −53,100 | $50.00 | −$885,070.8 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.